ארצות הברית - אנגלית - NLM (National Library of Medicine)

paddock laboratories, llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg

ארצות הברית - אנגלית - NLM (National Library of Medicine)

sandoz inc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

bayer new zealand limited - desloratadine 5mg;   - film coated tablet - 5 mg - active: desloratadine 5mg   excipient: calcium hydrogen phosphate dihydrate carnauba wax maize starch opadry blue 32b10817 opadry clear ys-1-19025-a powdered cellulose purified talc white beeswax - the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching, congestion/stuffiness, as well as ocular itching, tearing and redness, itching of palate and coughing.

סינגפור - אנגלית - HSA (Health Sciences Authority)

organon singapore pte. ltd. - desloratadine - tablet, film coated - 5 mg - desloratadine 5 mg

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

apotex nz ltd - desloratadine 5mg - film coated tablet - 5 mg - active: desloratadine 5mg excipient: colloidal silicon dioxide hydrogenated vegetable oil lactose microcrystalline cellulose opadry blue 03b50528 purified water starch

קנדה - אנגלית - Health Canada

pharmascience inc - desloratadine - tablet - 5mg - desloratadine 5mg - second generation antihistamines

ארצות הברית - אנגלית - NLM (National Library of Medicine)

physicians total care, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r), pseudoephedrine sulfate (unii: y9dl7qpe6b) (pseudoephedrine - unii:7cuc9ddi9f) - desloratadine 2.5 mg - clarinex-d® 12 hour extended release tablets is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis, including nasal congestion, in adults and adolescents 12 years of age and older. clarinex-d 12 hour extended release tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired [see clinical pharmacology (12)] . clarinex-d 12 hour extended release tablets are contraindicated in: - patients with hypersensitivity to any of its ingredients, or to loratadine [see warnings and precautions (5.4) and post-marketing experience (6.2)] - patients with narrow angle glaucoma - patients with urinary retention - patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment [see drug interactions (7.1)] . - patients with severe hypertension or severe coronary artery disease pregnancy category c: there are no adequate and well-controlled stu

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

actavis group ptc ehf - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - antihistamines for systemic use, - treatment of allergic rhinitis and urticaria.

הממלכה המאוחדת - אנגלית - myHealthbox

rosemont pharmaceuticals ltd - desloratadine - oral solution - 0.5mg/ml - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis - urticaria

מלטה - אנגלית - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - desloratadine - orodispersible tablet - desloratadine 5 mg - antihistamines for systemic use